Crimson Audit & Review

Content Audit, Review & Consulting for Medical Device Makers

China’s SFDA Sidesteps IP Question at RAPS Annual Conference

Posted by crimsonlanguage on 2011/10/25

Representatives of China’s SFDA were on hand at the 2011 RAPS Annual Conference to provide an update on regulatory developments in that country. However, what the delegations didn’t say in response to an audience question, was perhaps most interesting.

“On the one hand, SFDA has extensive requirements for product testing and technical file review. On the other hand, there are state-sponsored programs, such as the so-called ‘863 Program’ that are devoted to the acquisition of certain high-tech IP for the benefit of the domestic Chinese industry. Can you briefly describe the firewalls that exist between SFDA and the other state agencies to protect medical device IP?”

After a long, pregnant pause, the delegation merely referred to the Chinese office for intellectual property rights – saying that SFDA had no hand in addressing device IP. Of course, this is ridiculous – SFDA is in the busines of accumulating a vast amount of information for every device that enters the country. They are the conduit for US IP and their silence on the safeguards for that IP speaks volumes.

See my previous posts on Chinese Super-Competitors and IP theft.


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: